Journal article

Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha(2)-adrenoceptor agonists in acute pain models in mice

SM Tham, JA Angus, EM Tudor, CE Wright

British Journal of Pharmacology | WILEY | Published : 2005


1. Cannabinoid receptor agonists elicit analgesic effects in acute and chronic pain states via spinal and supraspinal pathways. We investigated whether the combination of a cannabinoid agonist with other classes of antinociceptive drugs exerted supra-additive (synergistic) or additive effects in acute pain models in mice. 2. The interactions between the cannabinoid agonist CP55,940, alpha2-adrenoceptor agonist dexmedetomidine and mu-opioid receptor agonist morphine were evaluated by isobolographic analysis of antinociception in hot plate (55 degrees C) and tail flick assays in conscious male Swiss mice. Drug interactions were examined by administering fixed-ratio combinations of agonists (s...

View full abstract